W e have previously reported that protein kinase C (PKC) ζ is proapoptotic in endothelial cell (EC).
1,2 Tumor necrosis factor (TNF) α activates PKCζ in EC 1 and induces its apoptosis, 3, 4 which contributes to vascular diseases such as atherosclerosis. 5 We are, therefore, interested in the mechanism of PKCζ-dependent EC apoptosis in response to TNFα stimulation.
Physiologically, PKCζ is the only PKC isoform that is activated specifically in EC exposed to proapoptotic disturbed flow. 6, 7 It is likely that PKCζ plays a critical role in EC dysfunction and apoptosis. 1, 2, 8 PKCζ belongs to the atypical PKC family of which binding to other regulatory proteins allosterically regulates their activities. 9 PKCζ is among 13 proteins in the mammalian genome that contains a Phox/Bem1p (PB1) domain. PB1 domains are recently recognized protein-protein interaction domains found in the atypical PKC isoenzymes, PKCλ/ι and PKCζ; members of mitogen-activated protein kinase modules such as mitogen extracellular signal-regulated kinase kinase 5, mitogen extracellular signal-regulated kinase kinase 2, and mitogen extracellular-signal regulated kinase kinase 3; and in several scaffold proteins involved in cellular signaling. [10] [11] [12] Of great interest is the fact that the PB1 domain-containing protein PKCζ is critical to TNFα signaling in EC. 1, 6 p62 is a scaffold protein that was initially identified by 2-hybrid screens as a binding partner of atypical PKC family. 13, 14 p62 has several domains that interact with other proteins, including, in the amino terminus region, a PB1 domain that can interact with other PB1 domain-containing proteins through PB1-PB1 interaction. 15 p62 has a proinflammatory role in various cell types. For example, p62 was critical for the sustained activation of nuclear factor (NF)-κB in response to NF-κB ligand activation and mediated the differentiation of osteoclasts. 16 p62 also mediated nerve growth factor-induced activation of the NF-κB pathway in PC12 cells. 17 In addition, p62 was an important mediator in Th2 cell differentiation 18 and tumorigenesis. 19 However, the role of p62 in EC remains unclear.
Thus, we investigated the function of p62 by focusing on its interaction with PKCζ in the PKCζ-mediated apoptotic signaling cascade in EC. To study the role of p62 in PKCζ activation, we used human umbilical vein EC (HUVEC) because we showed that these cells recapitulate many of the signaling events that occur in vivo. 5, 20, 21 We used TNFα to 
Materials and Methods

Cell Culture
HUVEC was isolated from collagenase-digested human umbilical veins and maintained in Medium 200 (Cascade Biologics, Portland, OR) supplemented with low serum growth supplement (Cascade Biologic), 5% fetal bovine serum (Gibco, Carlsbad, CA), 100 U/mL penicillin (Gibco), and 100 μg/mL streptomycin (Gibco). Cells were cultured on 2% gelatin-precoated dishes and used at passages 4 to 5. 
Sources of Materials
Western Blotting and Immunoprecipitation Assay
Cells were harvested and lysed in cell lysis buffer (Cell Signaling Technology) supplemented with protease inhibitor cocktail (Sigma). Cells were harvested and centrifuged at 13 000g for 10 minutes and supernatants collected. Protein concentration was determined by Bradford assay (Bio-Rad, Hercules, CA), and after heating at 95°C for 5 minutes, equivalent amounts of cell lysates were resolved by SDS-PAGE. Proteins were transferred onto nitrocellulose membranes and blocked for 1 hour at room temperature in 5% nonfat milk. Membranes were incubated overnight at 4°C with appropriate primary antibodies, followed by incubation in horseradish peroxidaseconjugated secondary antibody for 1 hour before development using an Immobilon Western Chemiluminescent Horseradish Peroxidase Substrate (Millipore, Billerica, MA). Densitometric analyses of immunoblots were performed with Image J software. For the immunoprecipitation assay, 500 μg of total protein was immunoprecipitated with 1 μg of PKCζ antibody or control IgG at 4°C overnight. Lysates were then incubated with 50 μL of protein A/G agarose beads (Santa Cruz Biotechnology) at 4°C for 2 hours. Immune complexes were collected by centrifugation (3000g for 3 minutes) and washed 5× with the cell lysis buffer. The bound proteins were released by heating in 2× SDS gel sample buffer and were resolved by SDS-PAGE.
MTT Assay
MTT assay was performed as previously described. 22 Briefly, cells were treated with TNFα (10 ng/mL)+cyclohexamide (CHX, 10 μg/ mL). After 24 hours, MTT (final 1 mg/mL) was added to cells and incubated at 37°C for 4 hours. When the purple precipitate was visible, the medium was removed and dimethylsulfoxide added to solubilize the formazan product. After shaking for 10 minutes to thoroughly mix the formazan with dimethylsulfoxide, the optical density at 590 nm was determined.
Statistics
Data are shown as mean±SD for 3 separate experiments. Analyses for 2 groups were performed using 1-way Student t test. Analyses for 4 groups were performed using repeated-measures 1-way ANOVA test. Values of P<0.05 were considered significant.
Results
TNFα Increases p62 Binding to PKCζ
Because both p62 and PKCζ contain PB1 domains, we first studied their interaction in response to TNFα stimulation. In confluent HUVEC, p62 and PKCζ exhibit a low level of interaction ( Figure 1A ). TNFα stimulation significantly increased the interaction with a peak at 15 minutes (1.9±0.2-fold compared with no TNFα stimulation; Figure 1B ).
TNFα Activates PKCζ via a p62-Dependent Pathway
After observing an increased interaction between p62 and PKCζ after TNFα stimulation, we hypothesized that this interaction is required for PKCζ activation. To study the role of p62, we depleted p62 using siRNA (J-010230-05) and measured TNFα-induced PKCζ activation. At the optimal concentration of p62 siRNA (80 nmol/L for 48 hours), expression was reduced by 92.8±1.8%, whereas 40 nmol/L siRNA reduced the p62 expression by 83.3±2.7% ( Figure  2A and 2B). After depletion of p62, TNFα-induced PKCζ activation was completely inhibited ( Figure 2C and 2D) . 
Depletion of p62 Suppresses TNFα-Induced PKCζ Signaling Cascade
We previously showed that TNFα-activated PKCζ led to the phosphorylation of JNK. 1 We and others have demonstrated that TNFα induced the cleavage of caspase 3 and the subsequent apoptosis of HUVEC when CHX was added together to inhibit protein synthesis. 5, 22, 23 Thus, we investigated the effect of p62 depletion on TNFα-induced JNK activation. As shown in Figure 3A and 3B, TNFα-induced time-dependent phosphorylation of JNK was significantly reduced in p62 siRNA (J-010230-05)-transfected HUVEC compared with scrambled siRNA. Furthermore, the expression of the cleaved form of caspase 3 (17/19 kDa) by TNFα+CHX treatment in p62 siRNA (J-010230-05)-transfected HUVEC was dramatically reduced compared with scrambled siRNA (Figure 3C and 3D) . Transfection of HUVEC with another p62 siRNA (D-010230-03) showed a similar inhibitory effect on both JNK activation and caspase 3 activation ( Figure IIB and IIC in the onlineonly Data Supplement). As caspase 8 is required for caspase 3-mediated apoptosis, 24 we examined whether caspase 8 is activated by PKCζ pathway. We depleted either PKCζ or p62 with siRNA transfection and stimulated transfected cells with 
Inhibiting the Interaction Between p62 and PKCζ Suppresses TNFα-Induced PKCζ Activation
To provide further support for the role of PB1 domain in mediating the p62-PKCζ interaction, we designed a peptide inhibitor ( Figure 4A ). Specifically, we thought that exogenous overexpression of the PB1 domain of p62 would compete with endogenous p62 and suppress the binding of p62 to PKCζ by occupying the p62-binding site on PB1 domain of PKCζ ( Figure 4A ). Consistent with our hypothesis, overexpression of the PB1 domain of p62 that was tagged by GFP (PB1-GFP) suppressed the interaction between p62 and PKCζ ( Figure  4B ). Furthermore, TNFα-induced PKCζ activation was completely inhibited by the PB1-GFP inhibitor ( Figure 4C and 4D). These data suggest that interaction between p62 and PKCζ is critical for the activation of PKCζ by TNFα.
Inhibiting p62 Binding to PKCζ Suppresses TNFα-Induced PKCζ Signaling Cascade
To study the effect of PB1-GFP on TNFα signaling, we measured the phosphorylation of JNK and cleavage of caspase 3 after overexpression of PB1-GFP. As shown in Figure 5A and 5B, the phosphorylation of JNK induced by TNFα stimulation was significantly reduced in PB1-GFP overexpressing HUVEC. Furthermore, the activation of caspase 8 and caspase 3 was significantly reduced in PB1-GFP overexpressing HUVEC ( Figure IIID in the online-only Data Supplement and Figure 5C and 5D). These data suggest that the interaction between the PB1 domains of p62 and PKCζ induced by TNFα stimulation (Figure 1 ) is important for the PKCζ signaling cascade.
Inhibition of p62 Binding to PKCζ Reduces EC Apoptosis
Activation of PKCζ induces EC apoptosis. 2 Thus, as a pathological outcome of p62, we examined whether p62 is required for EC apoptosis. First, we examined whether the inhibition of p62-PKCζ interaction would affect cell viability using an MTT assay. In scrambled siRNA-or pcDNA3.1-transfected control groups, TNFα+CHX treatment induced cell death ( Figure 6D ) increased cell viability. To show that the cell death was caused by apoptosis, 4'-6-diamidino-2-phenylindole-stained cell nuclei were analyzed, and the percentage of apoptotic cell death was calculated under fluorescence microscopy. TNFα+CHX treatment increased apoptosis in scrambled siRNA-or pcDNA3.1-transfected HUVEC. However, the number of apoptotic cells was significantly reduced in p62 siRNA-transfected (J-010230-05; Figure 6B and 6C or D-010230-03; Figure IVB and IVC in the online-only Data Supplement) or PB1-GFP-transfected HUVEC ( Figure 6E and 6F) . These results establish the critical role of p62 in PKCζ-mediated EC apoptosis.
Discussion
The major finding of this study is that the binding of p62 to PKCζ is critical for the activation of PKCζ, as well as downstream JNK activation, caspase 3 cleavage, and EC apoptosis. Specifically, we showed that binding of p62 to PKCζ occurred via the PB1 domains as shown by inhibition with the specific p62 PB1-GFP peptide. Based on our observations, we propose a new pathway for TNFα-mediated EC apoptosis ( Figure V in the online-only Data Supplement). In this model, TNFα increases PB1 domain-dependent interaction between p62 and PKCζ, probably changing the structure of PKCζ (eg, unfolding) and enabling activation of PKCζ. Subsequently, JNK activation and caspase 3 cleavage occur to induce EC apoptosis.
Previous studies have described a canonical mechanism of TNFα-induced apoptosis. Activation of TNFα receptor 1 by TNFα recruits TNFα receptor 1-associated death domain protein, which serves as a platform to subsequently recruit Fas-associated death domain and activate the initiator caspase, caspase 8. 24, 25 Then executioner caspase, caspase 3 is cleaved, leading to cell apoptosis. Previously, we showed that PKCζ was required for TNFα-mediated EC apoptosis via activation of caspase 3. 1, 8 There is 1 study which showed that p62 regulated caspase 8 activity. 26 However, the present study is the first to show that p62 binding to PKCζ via PB1 domains mediates caspase 8 and caspase 3 activation, leading to EC apoptosis.
Another possible mechanism by which PKCζ could promote EC apoptosis is by inhibiting NF-κB activity, because NF-κB downstream gene expression has been shown to inhibit TNFα-induced apoptosis. [27] [28] [29] Specifically, it has been reported by the laboratory of Moscat and Rahman that PKCζ is necessary for ligand-mediated phosphorylation of p65 (RelA) on serine 311, which activates NF-κB. 30 ,31 Therefore, we examined the involvement of NF-κB pathway in p62-PKCζ-dependent EC apoptosis. First, we depleted PKCζ and examined the phosphorylation of p65 Ser311. Surprisingly, we found that the depletion of PKCζ enhanced the TNFα-induced phosphorylation of p65 Ser311 ( Figure VIA in the online-only Data Supplement). To confirm that NF-κB was activated, we tested the effect of PKCζ depletion on cellular Fas-associated death domain-like interleukin-1β-converting enzyme-like inhibitory protein mRNA expression. As shown in Figure VIB in the online-only Data Supplement, PKCζ-depleted HUVEC showed a higher level of cellular Fas-associated death domainlike interleukin-1β-converting enzyme-like inhibitory protein mRNA in response to TNFα+CHX treatment. Because cellular Fas-associated death domain-like interleukin-1β-converting enzyme-like inhibitory protein expression depends on NF-κB activation, 32 these data support the concept that the NF-κB pathway is enhanced in PKCζ-depleted HUVEC. We believe that our results may differ from those reported by Moscat and Rahman as a result of the use of different cell types and stimuli in previous studies (TNFα-stimulated fibroblast 30 or lipopolysaccharide-exposed and cigarette smoke-exposed macrophages/monocytes), 31 compared with the present study (TNFα-stimulated EC). Consistent with the results of PKCζ depletion, when PKCζ activity was suppressed by either p62 depletion or PB1-GFP transfection, there was a similar increase in p65 Ser311 phosphorylation ( Figure VIC and VID in the online-only Data Supplement). These results suggest that inhibition of NF-κB by p62 PB1 domain-mediated PKCζ activation may enhance the TNFα-induced apoptosis. This seems to be another possible mechanism for PKCζ-regulated EC apoptosis and requires more study to fully understand this pathway.
The precise mechanism by which TNFα promotes p62-dependent activation of PKCζ is unknown. Although a direct interaction is possible, a complex that includes TNFα receptor 1 adaptor proteins such as TNF receptor-associated factor 6 may also be necessary. 33, 34 Our results suggest that the interaction between p62 and PKCζ is direct, because the transfection of GFP-tagged p62 PB1 domain inhibits activation of PKCζ, and there is no PB1 domain in TNF receptorassociated factor 6. Recently, pulmonary arteries from both p62 knockout mice and PKCζ knockout mice showed reduced Ca 2+ influx, 35 suggesting the similar function of p62 and PKCζ in the modulation of voltage-gated potassium channel function. Furthermore, both p62 knockout mice 18 and PKCζ knockout mice 36 rarely develop allergic airway inflammation because of reduced production of Th2 cytokine, including interleukin-4 and interleukin-13, which play important roles in airway inflammation such as asthma. 37 This supports the concept that p62 regulates PKCζ activity. Interestingly, it was reported that the interaction between PKCι and Par6 through a PB1-PB1 interaction is important for PKCι-dependent lung cancer cell growth. When their interaction was inhibited, lung cancer cell growth was suppressed because of reduced activation of the PKCι signaling cascade, including extracellular signal-regulated kinases-1/2 or Rac1. [38] [39] [40] These studies show the importance of PB1-PB1 interaction for atypical PKC family activation and strengthen our conclusion that p62 is an important binding partner for the activation of PKCζ in EC.
In combination with previous studies showing the important function of PKCζ in EC dysfunction, 1, 6, 8 our data suggest a key role for p62 in PKCζ-mediated EC apoptosis. Considering the potential proatherogenic function of PKCζ, 1,2,6,8 we believe that p62, specifically the PB1 domain, could be a good target for the development of therapy to limit atherosclerosis.
